Europe Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Neurothrombectomy Devices, Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices); Application (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, and Other Applications); End User (Hospitals, Ambulatory Surgical Centers, and Specialized Clinics) and Country

The Europe neurovascular devices market is expected to reach US$ 999.65 Mn in 2027 from US$ 773.41 Mn in 2019. The market is estimated to grow with a CAGR of 3.4% from 2020-2027.

Key factors that are driving growth of the Europe Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the Europe Neurovascular Devices market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.

Neurovascular devices are used for the treatment of neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems. The prevalence of cerebral aneurysms has increased tremendously across the globe. According to data published by NHS, the annual rate of rupture in the United Kingdom is found close to 1 per 12,500 people. A brain aneurysm ruptures every 18 minutes. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.

Additionally, several recent advances, such as favourable reimbursement policies, minimally invasive therapeutic modalities, and ongoing product development and commercialization, will drive market growth.

Moreover, COVID-19 pandemic has affected the market adversely. For instance, the limited availability of medical care for conditions other than COVID-19 around the world has negatively impacted the neurovascular market. Furthermore, the limited availability of healthcare staff across the globe will hamper the neurovascular devices market's growth.

Europe Neurovascular Devices Market Revenue and Forecast to 2027 (US$ Mn)

EUROPE NEUROVASCULAR DEVICES MARKET SEGMENTATION

By Product

• Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction & Aspiration Devices
  • Snares
• Aneurysm Coiling & Embolization Devices
  • Embolic Coils
    • Bare Detachable Coils
    • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
• Cerebral Balloon Angioplasty & Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
    • Balloon Occlusion Devices
    • Distal Fillers
• Support Devices
  • Microcatheters
  • Microguidewires

By Application

• Cerebral Aneurysms
• Arteriovenous Malformation & Fistulas
• Other Applications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics

By Country

• • UK
  • Germany
  • Spain
  • Italy
  • France

Company Profiles

• Medtronic plc
• Johnson and Johnson, Inc (DePuy Synthes)
• Penumbra, Inc
• Terumo Corporation
• MicroPort Scientific Corporation
• Integer Holdings Corporation
• Memry Corporation
• Phenox GmbH

Europe Neurovascular Devices Report Scope

1. Medtronic plc
2. Johnson and Johnson, Inc (DePuy Synthes)
3. Penumbra, Inc
4. Terumo Corporation
5. MicroPort Scientific Corporation
6. Integer Holdings Corporation
7. Memry Corporation
8. Phenox GmbH

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Neurovascular Devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Europe Neurovascular Devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.